Castleview Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Inflation Allocation ETF
RAAX
|
+$2.62M |
| 2 |
KKR & Co
KKR
|
+$2.48M |
| 3 |
Main Street Capital
MAIN
|
+$1.4M |
| 4 |
ConocoPhillips
COP
|
+$1.36M |
| 5 |
Albertsons Companies
ACI
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.41M |
| 2 |
VanEck Merk Gold Trust
OUNZ
|
+$1.42M |
| 3 |
PCMM
BondBloxx Private Credit CLO ETF
PCMM
|
+$1.28M |
| 4 |
ProShares Ultra QQQ
QLD
|
+$779K |
| 5 |
VanEck Commodity Strategy ETF
PIT
|
+$707K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.1% |
| 2 | Technology | 8.73% |
| 3 | Consumer Discretionary | 7.74% |
| 4 | Financials | 7.45% |
| 5 | Energy | 5.05% |
Similar funds
Castleview Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Castleview Partners held 210 positions worth $202M, up 9.6% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Castleview Partners deployed $15M of net new capital in Q4 2025, opening 34 new positions and adding to 96 existing holdings. Its largest new stake was VanEck Inflation Allocation ETF: 74,613 shares worth $2.61M.
By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $3.41M trimmed.
- Castleview Partners's largest Q4 2025 buy was VanEck Inflation Allocation ETF: 74,613 shares worth $2.61M.
- Castleview Partners added most to ConocoPhillips in Q4 2025, an estimated $1.36M increase.
- Castleview Partners's biggest Q4 2025 reduction was Apple, cutting an estimated $3.41M.
- Castleview Partners fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $509K.
- Castleview Partners's ten largest holdings make up 37% of its $202M portfolio in Q4 2025.
- Castleview Partners opened 34 new positions and closed 13 in Q4 2025.
- Castleview Partners's portfolio value rose 9.6% quarter-over-quarter to $202M.
Based on Castleview Partners's 13F filing for Q4 2025, filed 12 Jan 2026.